Invention Grant
- Patent Title: Factor IX polypeptides and methods of use thereof
-
Application No.: US13809276Application Date: 2011-07-11
-
Publication No.: US09670475B2Publication Date: 2017-06-06
- Inventor: Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
- Applicant: Glenn Pierce , Samantha Truex , Robert T. Peters , Haiyan Jiang
- Applicant Address: US MA Waltham
- Assignee: Bioverativ Therapeutics Inc.
- Current Assignee: Bioverativ Therapeutics Inc.
- Current Assignee Address: US MA Waltham
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- International Application: PCT/US2011/043569 WO 20110711
- International Announcement: WO2012/006624 WO 20120112
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N9/96 ; A61K38/48 ; A61K39/395
Abstract:
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Public/Granted literature
- US20130202595A1 Factor IX Polypeptides and Methods of Use Thereof Public/Granted day:2013-08-08
Information query
